11/26
07:03 am
legn
Legend Biotech (NASDAQ:LEGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Legend Biotech (NASDAQ:LEGN) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/13
03:27 pm
legn
Rating for LEGN
Report
Rating for LEGN
11/13
03:27 pm
legn
Rating for LEGN
Report
Rating for LEGN
11/13
12:35 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
11/13
12:35 pm
legn
Rating for LEGN
Low
Report
Rating for LEGN
11/13
09:07 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
10/9
09:44 am
legn
Rating for LEGN
Low
Report
Rating for LEGN
10/7
09:13 am
legn
Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $40.00 price target on the stock.
Low
Report
Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $40.00 price target on the stock.